Objective gustatory and olfactory dysfunction in COVID-19 patients: a prospective cross-sectional study.


Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 20 10 2020
accepted: 24 12 2020
pubmed: 21 1 2021
medline: 5 8 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

To determine the prevalence of objective gustatory (GD) and olfactory (OD) dysfunction in COVID-19 patients. This is a prospective, cross-sectional study of 51 COVID-19 positive patients diagnosed using RT-PCR-based testing. Of these study participants, 41 reported having present GD and OD at the time of enrollment and ten patients were without symptomatic OD and GD. All participants were objectively tested for OD by Brief Smell Identification Test (BSIT) and for GD by Burghart taste strip test, which were mailed to the participants. The subjective presence and severity of COVID-19 symptoms of smell loss, loss of taste, nasal obstruction, rhinorrhea/mucus production, fever, cough and shortness of breath were also assessed. Of the 41 patients with GD and OD, only 25.6% (10/39; p ≤ 0.0001) objectively presented GD and 39.1% (16/41; p ≤ 0.0001) OD at the time of their subjective dysfunction. Regarding GD, 23.1% (9/39) suffered from total hypogeusia, 2.6% (1/39) from ageusia. A significant loss of sour (33.3% (13/39)) and salty taste (17.9% (7/39)) could be recognized. Only 10.3% (4/39) showed a reduction in sweet and bitter taste. Concerning OD, 9.8% (4/41) showed a deficit relative to younger age in the BSIT and 29.3% (12/41) results abnormal relative to age. Subjective and objective findings in GD and OD differ significantly. Most patients suffering from objective dysgeusia present a deficit in sour and salty taste. DRKS00021516; 22/04/2020.

Identifiants

pubmed: 33471170
doi: 10.1007/s00405-020-06590-8
pii: 10.1007/s00405-020-06590-8
pmc: PMC7816141
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3325-3332

Subventions

Organisme : Kantonsspital Aarau
ID : KSA 1410.000.128

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.

Références

J Med Virol. 2020 Jun;92(6):552-555
pubmed: 32104915
J Neurol. 2009 Feb;256(2):242-8
pubmed: 19221845
Clin Allergy. 1988 Jan;18(1):29-37
pubmed: 3349590
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
Laryngoscope. 2020 Nov;130(11):2520-2525
pubmed: 32617983
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120
pubmed: 32423357
Cardiovasc Drugs Ther. 2015 Jun;29(3):201-6
pubmed: 26175121
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):246-7
pubmed: 26719421
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Infect Dis. 2020 Jul 28;71(15):889-890
pubmed: 32215618
Rhinology. 2020 Aug 1;58(4):404-405
pubmed: 32533768
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261
pubmed: 32253535
Percept Psychophys. 1989 May;45(5):381-4
pubmed: 2726398
Hypertens Res. 2020 Jul;43(7):648-654
pubmed: 32341442
Rhinology. 2003 Mar;41(1):2-6
pubmed: 12677732
Chem Senses. 1995 Dec;20(6):645-56
pubmed: 8788098
Rhinology. 2016 Mar;54(1):45-50
pubmed: 26462295
Nat Med. 2020 May;26(5):681-687
pubmed: 32327758
Curr Pharm Des. 2014;20(16):2669-83
pubmed: 23886383
Head Neck. 2020 Jul;42(7):1583-1590
pubmed: 32437033
J Neurosci. 2013 Apr 10;33(15):6267-77
pubmed: 23575826

Auteurs

Thirza Singer-Cornelius (T)

Klinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland. thirza.singer@ksa.ch.

Julian Cornelius (J)

Departement Chirurgie, Luzerner Kantonsspital, Lucerne, Switzerland.

Michael Oberle (M)

Institut für Labormedizin, Kantonsspital Aarau, Aarau, Switzerland.

Frank U Metternich (FU)

Klinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland.

Steffi Johanna Brockmeier (SJ)

Klinik für Hals-Nasen-Ohrenheilkunde, Hals- und Gesichtschirurgie, Kantonsspital Aarau, Aarau, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH